Source: https://www.law.cornell.edu/cfr/text/40/part-795/subpart-D
Timestamp: 2017-05-29 06:17:18
Document Index: 416667289

Matched Legal Cases: ['art 795', 'art 795', 'art 795', '§ 795', '§ 795', '§ 795', '§ 795', '§ 795', '§ 2603', '§ 2611', 'art 795', 'arts 721', 'arts 721']

40 CFR Part 795, Subpart D - Provisional Health Effects Guidelines | US Law | LII / Legal Information Institute
CFR › Title 40 › Chapter I › Subchapter R › Part 795 › Subpart D 40 CFR Part 795, Subpart D - Provisional Health Effects Guidelines
§ 795.225 Dermal pharmacokinetics of DGBE and DGBA.
§ 795.228 Oral/dermal pharmacokinetics.
§ 795.231 Pharmacokinetics of isopropanal.
§ 795.232 Inhalation and dermal pharmacokinetics of commercial hexane.
§ 795.250 Developmental neurotoxicity screen.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.United States CodeU.S. Code: Title 15 - COMMERCE AND TRADE§ 2603 - Testing of chemical substances and mixtures§ 2611 - Exports
Title 40 published on 10-May-2017 04:28The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 40 CFR Part 795 after this date.2012-08-03; vol. 77 # 150 - Friday, August 3, 201277 FR 46289 - Technical Corrections to Organizational Names, Addresses, and OMB Control Numbers
2012-05-24; vol. 77 # 101 - Thursday, May 24, 201277 FR 30972 - Certain Polybrominated Diphenylethers; Significant New Use Rule and Test Rule; Extension of Comment Period
typeregulations.gov FR Doc.2012-12625 RIN2070-AJ08 EPA-HQ-OPPT-2010-1039 FRL-9350-8 ENVIRONMENTAL PROTECTION AGENCY Proposed rule; extension of comment period. Comments, identified by docket identification (ID) number EPA-HQ-OPPT-2010-1039 must be received on or before July 31, 2012. 40 CFR Parts 721, 795, and 799 SummaryEPA issued a proposed rule in the Federal Register of April 2, 2012, that would amend the Toxic Substances Control Act (TSCA) section 5(a) Significant New Use Rule (SNUR) for certain polybrominated diphenylethers (PBDEs), and that would require persons that manufacture, import, or process any of three commercial PBDEs, including in articles, for any use after December 31, 2013, to conduct testing under TSCA section 4(a). This document extends the comment period for 60 days, from June 1, 2012 to July 31, 2012.
2012-04-02; vol. 77 # 63 - Monday, April 2, 201277 FR 19862 - Certain Polybrominated Diphenylethers; Significant New Use Rule and Test Rule
typeregulations.gov FR Doc.2012-7195 RIN2070-AJ08 EPA-HQ-OPPT-2010-1039 FRL-8889-3 ENVIRONMENTAL PROTECTION AGENCY Proposed rule. Comments must be received on or before June 1, 2012. 40 CFR Parts 721, 795, and 799 SummaryThe Agency is proposing to amend the Toxic Substances Control Act (TSCA) section 5(a) Significant New Use Rule (SNUR), for certain polybrominated diphenylethers (PBDEs) by: Designating processing of six PBDEs, or any combination of these chemical substances resulting from a chemical reaction, as a significant new use; designating manufacturing, importing, and processing of a seventh PBDE, decabromodiphenyl ether (decaBDE) for any use which is not ongoing after December 31, 2013, as a significant new use; and making inapplicable the article exemption for SNURs for this action. A person who intends to import or process any of the seven PBDEs included in the proposed SNUR, as part of an article for a significant new use would be required to notify EPA at least 90 days in advance to ensure that the Agency has an opportunity to review and, if necessary, restrict or prohibit a new use before it begins. EPA is also proposing a test rule under TSCA that would require any person who manufactures or processes commercial pentabromodiphenyl ether (c-pentaBDE), commercial octabromodiphenyl ether (c-octaBDE), or commercial decaBDE (c-decaBDE), including in articles, for any use after December 31, 2013, to conduct testing on their effects on health and the environment. EPA is proposing to designate all discontinued uses of PBDEs as significant new uses. The test rule would be promulgated if EPA determines that there are persons who intend to manufacture, import, or process c-pentaBDE, c-octaBDE, or c-decaBDE, for any use, including in articles, after December 31, 2013.